This brand name is authorized in Australia, Spain, France, Hong Kong, Ireland, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, United States
The drug VELETRI contains one active pharmaceutical ingredient (API):
|
1
Epoprostenol
UNII DCR9Z582X0 - EPOPROSTENOL
|
|
Epoprostenol sodium, the monosodium salt of epoprostenol, a naturally occurring prostaglandin produced by the intima of blood vessels. Epoprostenol is the most potent inhibitor of platelet aggregation known. It is also a potent vasodilator. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| VELETRI Powder for solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B01AC09 | Epoprostenol | B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10111E, 10117L, 10129D, 10130E |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 81076, 81077 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 60181231, 69903585 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 226474, 226477 |
| Country: HK | Department of Health Drug Office | Identifier(s): 66503, 66504 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 88772, 88773 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 33898, 52809 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 16506, 16507 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100304694, 100304702 |
| Country: SG | Health Sciences Authority | Identifier(s): 15405P, 15406P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699593270017, 8699593270024 |
| Country: US | FDA, National Drug Code | Identifier(s): 66215-402, 66215-403 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
